Arthritis

Methotrexate, Anakinra Combination Alternative For Disease Control

Published in Women's Health Weekly, December 6th, 2001

People with rheumatoid arthritis who take methotrexate but continue to have active arthritis may have further improvement in arthritis control with the addition of a new injectable treatment called anakinra, according to research presented at the American College of Rheumatology Annual Scientific Meeting in San Francisco, California.

The results of this study confirm previous findings that anakinra (IL-1ra), an inhibitor of interleukin-1, is effective in improving signs and symptoms and physical function of rheumatoid arthritis patients with active disease despite on-going methotrexate treatment. Additionally, anakinra was well tolerated with the most common adverse...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-12-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry